NBIX vs TASK
Neurocrine Biosciences Inc (NBIX) versus Taskus Inc (TASK) — a side-by-side from cached financials, not a winner call.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Taskus Inc (TASK) is a information technology services company listed on NASDAQ.
Latest reported NBIX revenue for 2024-12-31 was $2.36B. Net income was $341.3M. Revenue was up 24.8% from 2023-12-31 to 2024-12-31. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Latest reported TASK revenue for 2024-12-31 was $995.0M. Net income was $45.9M. Revenue was up 7.6% from 2023-12-31 to 2024-12-31. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
NBIX currently screens at market cap $13.21B and trailing P/E 45.2. TASK currently screens at market cap $492.7M and trailing P/E 4.8.
Not investment advice. Open the NBIX and TASK stock pages for the full models.
Not investment advice.